<?xml version="1.0" encoding="UTF-8"?>
<Label drug="renacidin" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  The most common adverse reactions with use of Renacidin for dissolution of bladder calculi or prevention of encrustations of indwelling urethral catheters are "bladder irritability" and chemical cystitis, both reported to occur in approximately 3% of patients. A transient burning sensation in the bladder following Renacidin has been reported to occur in less than 1% of patients receiving Renacidin.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
